Lmr Partners LLP Alnylam Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

$8.3 Billion
Q1 2025

A detailed history of Lmr Partners LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 9,000 shares of ALNY stock, worth $2.81 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,000

Previous 11,901 24.38%

Holding current value

$2.81 Million

Previous $2.8 Million 13.21%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$233.07 - $290.7 $676,136 - $843,320	-2,901 Reduced 24.38%	9,000 $2.43 Million
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $12.9 Million - $16.7 Million	-55,588 Reduced 82.37%	11,901 $2.8 Million
Q3 2024 Nov 07, 2024	BUY	$233.81 - $287.01 $13.7 Million - $16.8 Million	58,518 Added 652.3%	67,489 $18.6 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $8.94 Million - $15.4 Million	-62,400 Reduced 87.43%	8,971 $2.18 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $6.32 Million - $8.56 Million	43,171 Added 153.09%	71,371 $10.7 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $5.98 Million - $7.77 Million	-39,524 Reduced 58.36%	28,200 $5.4 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $5.64 Million - $6.99 Million	33,029 Added 95.2%	67,724 $12 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $2.51 Million - $2.87 Million	13,551 Added 64.09%	34,695 $6.59 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $3.86 Million - $4.98 Million	21,144 New	21,144 $4.24 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $18.6 Million - $31.1 Million	-134,266 Reduced 97.03%	4,107 $822,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $5.57 Million - $7.83 Million	46,259 Added 50.22%	138,373 $20.2 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $8.89 Million - $12.2 Million	69,886 Added 314.41%	92,114 $15 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $3.55 Million - $4.65 Million	22,228 New	22,228 $3.77 Million
Q4 2017 Jan 30, 2018	SELL	$114.49 - $139.98 $5.79 Million - $7.08 Million	-50,588 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$72.53 - $118.27 $3.67 Million - $5.98 Million	50,588	50,588 $5.94 Million

Others Institutions Holding ALNY

# of Institutions

720

Shares Held

111M

Call Options Held

978K

Put Options Held

881K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $38.4B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account